Marianne Davies Discusses Side Effects Associated With Immunotherapy
Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the side effects associated with immunotherapy.
Marianne Davies on Determining Patient Eligibility for Immunotherapy
Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses how to determine which patients are eligible for immunotherapy.
Marianne Davies Discusses Managing Immunotherapy Side Effects
Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the challenges of managing side effects from immunotherapy treatments.
Marianne Davies Discusses Chemotherapy Safety for Nurses and Patients
Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the importance of chemotherapy safety.
Marianne Davies on Evidence- Based Practice at YNHH
Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the benefits of the nursing research and evidence-based practice council at Yale-New Haven Hospital.
PVd Confers a Small OS Benefit to Patients With Relapsed/Refractory Multiple Myeloma
Neoadjuvant Durvalumab Combination Misses Mark in EGFR+ NSCLC
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
